Concurrent paclitaxel versus cisplatin with external beam radiotherapy in locally advanced head and neck cancer patients: a comparative study

M. Ershadul Haque; Ahammad A. M. Sweet; Aditi P. Chowdhury; M. Nazmul Alam; Barun Kumar; M. Shahidul Islam; Deepak S. Ray; M. A. Bari

doi:10.18203/2320-6012.ijrms20243690

Authors

M. Ershadul Haque Department of Radiotherapy, Rangpur Medical College Hospital, Rangpur, Bangladesh
Ahammad A. M. Sweet Department of Clinical and Radiation Oncology, Labaid Cancer Hospital and Super Speciality Centre, Dhaka, Bangladesh
Aditi P. Chowdhury Ahsania Mission Cancer and General Hospital, Dhaka, Bangladesh
M. Nazmul Alam Department of Oncology, Khwaja Yunus Ali Medical College Hospital, Sirajganj, Bangladesh
Barun Kumar Department of Oncology, Khwaja Yunus Ali Medical College Hospital, Sirajganj, Bangladesh
M. Shahidul Islam Department of Clinical Oncology, BSMMU, Bangladesh
Deepak S. Ray Department of Oncology, Khwaja Yunus Ali Medical College Hospital, Sirajganj, Bangladesh
M. A. Bari Department of Oncology, Khwaja Yunus Ali Medical College Hospital, Sirajganj, Bangladesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20243690

Keywords:

External beam radiotherapy, Efficacy, Head and neck cancer, Histopathology

Abstract

Background: The management of locally advanced head and neck cancer (HNC) requires a multidisciplinary approach. With a paradigm shift towards organ preservation, concurrent chemo radiation (CCRT) has taken a more centralized place in the management of HNC. This study aimed to compare the efficacy of CCRT with weekly paclitaxel versus weekly cisplatin in locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Methods: This quasi-experimental study was conducted at the Department of Oncology, Khwaja Yunus Ali Medical College and Hospital (KYAMCH), Enayetpur, Sirajganj, from June 2019 to December 2020. A total of 64 patients were selected by purposive sampling technique. Study subjects were divided into 2 arms- arm A and arm B, each arm contained 32 patients.

Results: In Arm A, 53.12% showed complete response (CR) whereas in arm B, CR showed 62.5%. Partial response was 31.25% and 28.12% in Arm A & B, respectively. Stable disease was 9.37% & 6.25% in Arm A & B, respectively. Two patients in Arm A and one patient in Arm B showed progressive disease at the final follow-up. The difference was statistically not significant (p>0.05).

Conclusions: This study concludes that patients receiving paclitaxel showed comparatively more response to treatment than those receiving cisplatin. So, CCRT by low dose weekly Paclitaxel given in conventional fractionation can be substituted to concurrent Cisplatin in locally advanced SCCHN in terms of efficacy and some manageable local toxicities.

Metrics

Metrics Loading ...

References

Weinberg RA. The Biology of Cancer. 2nd Edition. W. W. Norton & Company. 2013.

National Institute of Cancer Research & Hospital, Hospital Cancer Registry Report 2015-2017. Mohakhali, Dhaka. Available at: https://nicrh.gov. bd/images/reports/5bd09-hbcr-2015-2017. Accessed on 12 September 2024.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines Oncology. 2020. Available at: www.nccn.org/professionals/physician _gls/default.aspx. Accessed on 12 September 2024.

Pignon JP, Le Maitre A, Maillard E, Bourhis J; MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomized trials and 17,346 patients. Radiother Oncol. 2009;92(1):4-14.

Overgaard J, Hansen HS, Overgaard M, Bastholt L, Berthelsen A, Specht L, et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother Oncol. 1998;46(2):135-46.

Forastiere AA, Shank D, Neuberg D, Taylor SG 4th, DeConti RC, Adams G. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390). Cancer. 1998;82(11):2270-4.

Schrijvers D, Vermorken JB. Role of taxoids in head and neck cancer. Oncologist. 2000;5(3):199-208.

Citrin D, Mansueti J, Likhacheva A, Sciuto L, Albert PS, Rudy SF, et al. Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009;74(4):1040-6.

Pradier O, Laurent D, Schmidberger H, Rave-Fränk M, Rubisch K, Krebeck M, et al. In vitro study of a paclitaxel-radiotherapy combination on a human epidermoid tumor cell line. Cancer Radiother. 1999;3(1):51-6.

Smith RE, Thornton DE, Allen J. A phase II trial of Paclitaxel in squamous cell carcinoma of the head and neck with correlative laboratory studies. Semin Oncol. 1995;22(3):41-46.

Posner MR, Haddad RI, Wirth L, Norris CM, Goguen LA, Mahadevan A, et al. Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach. Semin Oncol. 2004;31(6):778-85.

Bari MA, Alam S, Sharmin S, Nahar S, Uddin J, Aslam N. Outcome of Concurrent Chemoradiotherapy and Radiotherapy Alone Following Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of Head and Neck. Bangl Med Res Council Bull. 2018;44(2):93-7.

Posner MR, Haddad RI, Wirth L, Norris CM, Goguen LA, Mahadevan A, et al. Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach. Semin Oncol. 2004;31(6):778-85.

Das TK, Chatterjee K, Das S. A prospective comparative study. International Journal of Medical Science Public Health. 2020;9(1):97-100.

Kanotra SP, Kanotra S, Gupta A. Chemoradiation in advanced head and neck cancers: a comparison of two radiosensitizers, Paclitaxel and Cisplatin. Indian J Otolaryngol Head Neck Surg. 2011;63(3):229-36.

Drau HK, Devi YS, Singh LJ. A study of weekly paclitaxel vs weekly cisplatin with concomitant chemoradiation in locally advanced head and neck cancer. Int J Res Med Sci. 2017;5(11):4895-902.

Jain RK, Kirar P, Gupta G, Dubey S, Gupta SK, Goyal J. A comparative study of low dose weekly paclitaxel versus cisplatin with concurrent radiation in the treatment of locally advanced head and neck cancers. Indian J Cancer. 2009;46(1):50-3.